Latest filing published 21 Aug 2026 for Medpace Holdings, Inc., €220k. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
This profile gathers the share dealings of Fred B. Davenport Jr. in Medpace Holdings, Inc., where the filings describe the role as senior executive. Over a trading history stretching from 17 February 2022 to 19 August 2026, the count stands at 7 filings.
On the open market, the record shows 1 purchase worth €64k and 1 sale worth €3.8M. The net balance comes to €3.7M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 5 option exercises. Since January 2026: no purchases and 1 sale on the market.
The record was last updated on 21 August 2026 with an option exercise (€281k) in Medpace Holdings, Inc. The last purchase on record was published on 22 February 2022, which is 1,699 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations